6869.T实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 14:15):

Stats
今日成交量	1.10M
平均成交量	1.66M
市值	1 550.87B
EPS	¥0 ( 2024-02-08 )
下一个收益日期	( ¥25.37 ) 2024-05-08
Last Dividend	¥2.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	34.60
ATR14	¥1.939 (0.08%)

音量相关性

長: -0.27 (neutral)

短: 0.57 (weak)

Signal:(55.758) Neutral

Sysmex Corporation 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Sysmex Corporation 相关性 - 货币/商品

-0.36
( neutral )

-0.48
( neutral )

0.08
( neutral )

-0.18
( neutral )

-0.58
( weak negative )

0.03
( neutral )

Sysmex Corporation 财务报表

Annual	2022
营收:	¥410.50B
毛利润:	¥216.08B (52.64 %)
EPS:	¥72.94

FY	2022
营收:	¥410.50B
毛利润:	¥216.08B (52.64 %)
EPS:	¥72.94

FY	2022
营收:	¥363.78B
毛利润:	¥190.59B (52.39 %)
EPS:	¥210.88

FY	2021
营收:	¥305.07B
毛利润:	¥154.30B (50.58 %)
EPS:	¥158.65

Financial Reports:

No articles found.

Sysmex Corporation Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥40.00 (N/A)	¥0 (N/A)	¥2.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Sysmex Corporation Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.53 - Stable (30.68%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥1.500	2001-03-27
Last Dividend	¥2.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	46	--
Total Paid Out	¥628.25	--
Avg. Dividend % Per Year	0.00%	--
Score	4.35	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	6.53
Div. Directional Score	9.65	--

Next Divdend (Est)
(2024-07-03)

¥0 Estimate 1.26 %

Dividend Stability

0.10 Bad

Dividend Score

4.35

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
3464.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
2651.T	Ex Dividend Knight	2024-02-28	Semi-Annually	0.00%
9514.T	Ex Dividend Junior	2024-06-27	Annually	0.00%
8129.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7467.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6699.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
6030.T	Ex Dividend Knight	2023-06-29	Annually	0.00%
4719.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3962.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
3172.T	Ex Dividend Knight	2024-01-30	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.103	1.500	7.94	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0794	1.200	7.35	8.82	[0 - 0.3]
returnOnEquityTTM	0.112	1.500	9.87	10.00	[0.1 - 1]
payoutRatioTTM	0.390	-1.000	6.10	-6.10	[0 - 1]
currentRatioTTM	3.10	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	1.972	0.800	3.11	2.49	[0.8 - 2.5]
cashRatioTTM	0.603	1.500	7.76	10.00	[0.2 - 2]
debtRatioTTM	0.0882	-1.500	8.53	-10.00	[0 - 0.6]
interestCoverageTTM	37.92	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	108.38	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	28.58	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.123	-1.500	9.51	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.532	1.000	4.47	4.47	[0.2 - 0.8]
operatingProfitMarginTTM	0.168	1.000	8.65	8.65	[0.1 - 0.6]
cashFlowToDebtRatioTTM	1.355	1.000	3.58	3.58	[0.2 - 2]
assetTurnoverTTM	0.773	0.800	8.18	6.55	[0.5 - 2]
Total Score				12.77

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	34.55	1.000	6.61	0	[1 - 100]
returnOnEquityTTM	0.112	2.50	9.92	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	28.58	2.00	0.474	10.00	[0 - 30]
dividendYielPercentageTTM	2.25	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	108.38	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0.390	1.500	6.10	-6.10	[0 - 1]
pegRatioTTM	0.907	1.500	7.28	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.155	1.000	8.63	0	[0.1 - 0.5]
Total Score				6.53

Sysmex Corporation

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. It also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, the company offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; cancer genome profiling systems; and cytogenic testing and lab assay services. It is also involved in the development and sale of software for diagnostic information systems; provision of facility management, office, and welfare services; development, manufacture, and sale of nucleic acid analogs; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. Sysmex Corporation has a strategic alliance with QIAGEN N.V. for the development and commercialization of cancer companion diagnostics using Plasma-Safe-SeqS technology. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.